Some good reasons to proceed with the occlusion of the auricle

Area of Science:

• Cardiology
• Interventional Cardiology
• Electrophysiology

Background:

• Atrial fibrillation (AF) is the most common cardiac arrhythmia, significantly increasing the risk of cardio-embolic stroke.
• Oral anticoagulant therapy (OAT) is the standard for preventing AF-related strokes, but is unsuitable for patients with high bleeding risk or contraindications.
• Some patients experience embolic events despite adequate OAT, necessitating alternative strategies.

Purpose of the Study:

• To evaluate left atrial appendage closure (LAAC) as an alternative to OAT in specific AF patient populations.
• To assess the safety and efficacy of LAAC in reducing thromboembolic events and bleeding complications.
• To explore LAAC's role for patients with contraindications or inadequate response to OAT.

Main Methods:

• Percutaneous closure of the left atrial appendage (LAA) was performed.
• Patient cohorts included those with high bleeding risk and those with embolic events despite OAT.
• Outcomes assessed included procedural safety, reduction in bleeding risk, and prevention of cardio-embolic events.

Main Results:

• LAAC proved to be an effective and safe interventional procedure.
• The procedure significantly reduced bleeding risks, potentially eliminating the need for long-term OAT.
• LAAC demonstrated efficacy in mitigating cardio-embolic risk associated with AF.

Conclusions:

• Left atrial appendage closure (LAAC) is a viable alternative to OAT for AF patients with contraindications or high bleeding risk.
• LAAC offers a significant reduction in bleeding complications compared to long-term OAT.
• Further research is needed to determine optimal post-LAAC antithrombotic therapy.